1-65565843-TCTCA-T

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2

The NM_002303.6(LEPR):​c.40+240_40+243del variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0064 ( 12 hom., cov: 11)

Consequence

LEPR
NM_002303.6 intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.129
Variant links:
Genes affected
LEPR (HGNC:6554): (leptin receptor) The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP6
Variant 1-65565843-TCTCA-T is Benign according to our data. Variant chr1-65565843-TCTCA-T is described in ClinVar as [Likely_benign]. Clinvar id is 1203311.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00643 (968/150510) while in subpopulation NFE AF= 0.0103 (697/67684). AF 95% confidence interval is 0.00966. There are 12 homozygotes in gnomad4. There are 449 alleles in male gnomad4 subpopulation. Median coverage is 11. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LEPRNM_002303.6 linkuse as main transcriptc.40+240_40+243del intron_variant ENST00000349533.11 NP_002294.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LEPRENST00000349533.11 linkuse as main transcriptc.40+240_40+243del intron_variant 1 NM_002303.6 ENSP00000330393 P4P48357-1

Frequencies

GnomAD3 genomes
AF:
0.00641
AC:
964
AN:
150404
Hom.:
12
Cov.:
11
show subpopulations
Gnomad AFR
AF:
0.00231
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00491
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.000396
Gnomad SAS
AF:
0.00462
Gnomad FIN
AF:
0.000967
Gnomad MID
AF:
0.0256
Gnomad NFE
AF:
0.0103
Gnomad OTH
AF:
0.00975
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00643
AC:
968
AN:
150510
Hom.:
12
Cov.:
11
AF XY:
0.00611
AC XY:
449
AN XY:
73476
show subpopulations
Gnomad4 AFR
AF:
0.00232
Gnomad4 AMR
AF:
0.00490
Gnomad4 ASJ
AF:
0.0107
Gnomad4 EAS
AF:
0.000397
Gnomad4 SAS
AF:
0.00526
Gnomad4 FIN
AF:
0.000967
Gnomad4 NFE
AF:
0.0103
Gnomad4 OTH
AF:
0.00965
Alfa
AF:
0.00780
Hom.:
0
Bravo
AF:
0.00628

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 29, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1440292866; hg19: chr1-66031526; API